Mei Ri Jing Ji Xin Wen·2025-09-10 13:48Mergers and Acquisitions - Dongyangguang plans to jointly increase capital in Yichang Dongshu No.1 Investment Co., Ltd. with an associated party, with capital increases of 3.5 billion and 4 billion yuan respectively. The company intends to acquire 100% equity of Qinhuai Data's China operations through its wholly-owned subsidiary Yichang Dongshu No.3 Investment Co., Ltd. [1] - Aimeike has completed the acquisition of controlling interest in South Korea's REGEN Biotech, Inc. Aimeike International now holds 85% of REGEN, translating to an actual ownership of 59.5% by Aimeike. [2] - Longzi Co., Ltd. plans to acquire 67.5% equity of Chongqing Milan Baiyu Time Aesthetic Medical Hospital Co., Ltd. for 92.475 million yuan. [3] Shareholding Changes - Hongbai New Materials' controlling shareholder plans to reduce its stake by up to 3%, which includes a maximum of 6.5 million shares through centralized bidding and 13 million shares through block trading. [4] - BYD executives and core personnel collectively increased their holdings by 488,200 shares of A-shares, with a total investment of 52.3278 million yuan. [5] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2%, equating to a maximum of 17.4 million shares. [6]